Reimbursing the value of gene therapy care in an era of uncertainty
Sign Up to like & getrecommendations! Published in 2020 at "Haemophilia"
DOI: 10.1111/hae.14218
Abstract: Early‐stage gene therapy (GT) clinical trials are demonstrating exciting results for persons with haemophilia (PWH), with the first products possibly licenced over the next few years for haemophilia A and B. These new treatments offer… read more here.
Keywords: uncertainty; gene therapy; value gene; reimbursing value ... See more keywords